Sionna Therapeutics, Inc.
SION$1.96B
Small CapNASDAQBiotechnology🇺🇸North America41 employees
Drugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Jul 15, 2026
13wMarket Overview
Stock performance and key metrics
SION News
Catalyst Timeline
2 upcoming, 0 past
ConferenceNext
Conference Presentation
Apr 14, 2026AI-detected
Sionna Therapeutics will participate in the Raymond James 2026 Biotech Innovation Symposium on April 14, 2026, where management will hold one-on-one investor meetings. The company is developing novel CFTR-normalizing medicines for cystic fibrosis treatment.
1 more catalyst beyond 14 days
Start a 48h free trial to see all upcoming catalysts
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
SION-719 | Phase 2 | Cystic Fibrosis (CF) | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply